In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016)
被引:0
|
作者:
Duncan, Leonard R.
论文数: 0引用数: 0
h-index: 0
机构:
JMI Labs, North Liberty, IA 52317 USAJMI Labs, North Liberty, IA 52317 USA
Duncan, Leonard R.
[1
]
Flamm, Robert K.
论文数: 0引用数: 0
h-index: 0
机构:
JMI Labs, North Liberty, IA 52317 USAJMI Labs, North Liberty, IA 52317 USA
Flamm, Robert K.
[1
]
Sader, Helio S.
论文数: 0引用数: 0
h-index: 0
机构:
JMI Labs, North Liberty, IA 52317 USAJMI Labs, North Liberty, IA 52317 USA
Sader, Helio S.
[1
]
Mendes, Rodrigo E.
论文数: 0引用数: 0
h-index: 0
机构:
JMI Labs, North Liberty, IA 52317 USAJMI Labs, North Liberty, IA 52317 USA
Pneumonia and skin and skin structure infections (SSSIs) caused by S. aureus can lead to serious bloodstream infections (BSIs). This study reports on potent telavancin in vitro activity (MIC90, 0.06 mu g/mL; 100% susceptible) against 674 US S. aureus causing pneumonia or SSSI with associated BSI in hospitalized patients during 2012-2016. (C) 2018 The Authors. Published by Elsevier Inc.